$1.80 -0.01 (-0.55%)
2/10/2012 3:59 PM

ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Featured Broker Partners


Advertisement